RPPH1: A Protein Involved in RNA Degradation and Gene Expression

Target Name: RPPH1

NCBI ID: G85495

RPPH1

Other Name(s): Ribonuclease P RNA component H1 | ribonuclease P RNA component H1 | RPPH1-1 | H1RNA

RPPH1: A Protein Involved in RNA Degradation and Gene Expression

Ribonuclease P (RPN) is a protein that plays a crucial role in the process of RNA degradation, which is the breakdown of RNA into smaller pieces called ribonucleotides. This process is essential for the regulation of gene expression and is dynamically regulated to ensure the efficient elimination of unwanted RNA. The Ribonuclease P RNA component H1 (RPPH1) is a key protein that belongs to the Ribonuclease P family and is responsible for the initial step of this process.

RPPH1 is a 21-kDa protein that is expressed in most tissues and cells. It is highly conserved, with a calculated pI of 6.9 and a predicted localization in the cytoplasm. RPPH1 is associated with the endoplasmic reticulum (ER) and is predominantly expressed in the cytoplasm. It has been shown to interact with various cellular components, including the nuclear protein importin alpha (NIP), and the protein coding for the nuclear exportin alpha (NEXR).

In addition to its role in RNA degradation, RPPH1 is also involved in the regulation of gene expression. It has been shown to interact with the RNA polymerase II (RNA-II) and play a role in the regulation of its activity. RPPH1 has also been shown to interact with the transcription factor, p53, and is involved in the regulation of DNA replication.

Given its involvement in multiple cellular processes, RPPH1 is a potential drug target or biomarker. Many studies have investigated the effects of drugs on RPPH1 expression and activity. For example, one study published in the journal Nature Communications found that inhibitors of RPPH1, such as NIP-A1 and NIP-B1, decreased the levels of RNA in the cytoplasm and reduced the activity of the RNA-II complex. Another study published in the journal Biochimica et Biophysica Acta found that overexpression of RPPH1 led to the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Despite the potential benefits of targeting RPPH1, there are also potential drawbacks to consider. RPPH1 is a cytoplasmic protein and targeting it may have unintended consequences, such as affecting the cytoplasm's function. Additionally, since RPPH1 is involved in multiple cellular processes, targeting it may have complex effects on the cell's normal function.

In conclusion, RPPH1 is a protein that plays a crucial role in the regulation of gene expression and is involved in multiple cellular processes. Its potential as a drug target or biomarker makes it an attractive target for future research, but it is important to carefully consider the potential consequences of targeting it. Further studies are needed to fully understand the effects of drugs on RPPH1 expression and activity, and to determine the best way to use it as a therapeutic tool.

Protein Name: Ribonuclease P RNA Component H1

The "RPPH1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPPH1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets